Suppr超能文献

牛奶过敏的新概念。

New concepts of allergy to cow's milk.

作者信息

Suomalainen H, Isolauri E

机构信息

Helsinki University Central Hospital, Department of Allergy and Skin Diseases, Finland.

出版信息

Ann Med. 1994 Aug;26(4):289-96. doi: 10.3109/07853899409147904.

Abstract

CMA is a diagnostic and therapeutic problem in the field of pediatrics. The response to oral cow's milk challenge was evaluated in patients with suspective CMA. To investigate immune mechanisms in different subtypes of CMA, suppressor activity, in vitro IFN-gamma and IL-4 generation, eosinophil activation and humoral immune response were measured. Also, changes in the function of the immune system were evaluated when patients had clinically recovered from CMA. The results of different measurements were correlated with the patients' clinical response to cow's milk challenge. The prechallenge suppressor activity was found to be low in patients with challenge-proven CMA when compared with those clinically negative to oral cow's milk challenge but had normalized after a 4-18 month milk-elimination period in patients who had recovered from CMA. IFN-gamma generation was low in patients with active CMA but had clearly enhanced in patients recovering from CMA. The serum concentration of ECP increased significantly during oral cow's milk challenge in patients with cutaneously manifested CMA. Measured by the ELISPOT method, the patients with active CMA mounted a high, non-antigen-specific immune response but were unable to direct the antigen-specific response, especially in the IgA class. After a follow-up of a mean 13.5 months on cow's milk elimination diet, the immune response to cow's milk antigens had developed in patients who had recovered from CMA. The development in the capacity to mount an adequate immune response to specific protein antigens, especially in the IgA class, can be interpreted as deriving from the development in T-lymphocyte regulation.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

牛奶蛋白过敏是儿科学领域的一个诊断和治疗难题。对疑似牛奶蛋白过敏的患者进行了口服牛奶激发试验的反应评估。为了研究不同亚型牛奶蛋白过敏的免疫机制,测定了抑制活性、体外干扰素-γ和白细胞介素-4的产生、嗜酸性粒细胞活化及体液免疫反应。此外,还评估了患者从牛奶蛋白过敏临床康复后免疫系统功能的变化。不同测量结果与患者对牛奶激发试验的临床反应相关。结果发现,与口服牛奶激发试验临床阴性的患者相比,激发试验证实为牛奶蛋白过敏的患者激发前抑制活性较低,但从牛奶蛋白过敏康复的患者在4至18个月的牛奶排除期后抑制活性恢复正常。活动期牛奶蛋白过敏患者的干扰素-γ产生较低,但从牛奶蛋白过敏康复的患者明显增强。皮肤表现为牛奶蛋白过敏的患者在口服牛奶激发试验期间血清嗜酸性粒细胞阳离子蛋白浓度显著增加。通过酶联免疫斑点法测量,活动期牛奶蛋白过敏患者产生高的非抗原特异性免疫反应,但无法引导抗原特异性反应,尤其是IgA类反应。在平均13.5个月的牛奶排除饮食随访后,从牛奶蛋白过敏康复的患者对牛奶抗原产生了免疫反应。对特定蛋白质抗原,尤其是IgA类抗原产生充分免疫反应的能力发展可解释为源于T淋巴细胞调节的发展。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验